Results 101 to 110 of about 1,004,480 (189)

A novel myeloid cell in murine spleen defined through gene profiling [PDF]

, 2019
Dabiri GA, Ghosh S, Helen C. O’Neill, Schiopu A, Terence J. O’Neill, Ying‐Ying Hey   +5 more
core   +1 more source

Architecture of the human B-cell antigen receptors [PDF]

Blood, 1993
C J, van Noesel, R A, van Lier
openaire   +3 more sources

A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell types. [PDF]

Proc Natl Acad Sci U S A
Ahmad S, Xing K, Pereira MSF, Castle S, Rajakaruna H, Nayak I, Stewart WC, Beckwith KA, Cairo MS, Naeimi Kararoudi M, Lee DA, Das J.   +11 more
europepmc   +1 more source

Post-translational modification of NK cell receptors offers clues to antigenic specificity riddle. [PDF]

Front Immunol
Ustiuzhanina MO, Kovalenko EI, Chudakov DM.   +2 more
europepmc   +1 more source

Advances in Therapeutic Antibody Discovery and Development Targeting G Protein-Coupled Receptors. [PDF]

Pharmacol Res Perspect
Hutchings CJ, Ünsal S, Rappas M, Barnes M, Waldhoer M, Holland B, Culka M.   +6 more
europepmc   +1 more source

Toll like receptor agonist effects on human CD8+ T cell activation and expression of T cell checkpoint receptors. [PDF]

Hum Vaccin Immunother
Jeon D, Moseman JE, Hill E, McNeel DG.
europepmc   +1 more source

Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy. [PDF]

Int J Mol Sci
Sioud M, Casey NP.
europepmc   +1 more source

Engineering the next generation of CAR T- cells: precision modifications, logic gates and universal strategies to overcome exhaustion and tumor resistance. [PDF]

Front Oncol
Garcia-Robledo JE, Cabrera-Salcedo S, Brandauer AM, Romano F, Rengifo-Martinez J, Toro-Pedroza A, Victoria JS, Rios-Serna LJ, Loukanov A, Cardona AF, Genovese P, Baena JC.   +11 more
europepmc   +1 more source

Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances. [PDF]

Int J Mol Sci
Kurilin V, Fisher M, Obleukhova I, Sennikov S.   +3 more
europepmc   +1 more source

Overcoming Resistance and Relapse in CAR-T and CAR-NK Cell Therapies: From Bench to Bedside. [PDF]

Research (Wash D C)
Wang Y, Shao W, Mao J, Ye Q.
europepmc   +1 more source